Global Interventional Pulmonology Market: Restraint
The major factors that hinder growth of the global interventional pulmonology market include product recalls. For instance, in August 2020, Olympus Corporation’s BF-Q180 bronchoscope was recalled as it did not have a 510(k) clearance, and the device is associated with a higher rate of patient infections than other comparable Olympus Medical Systems Corporation bronchoscopes.
Interventional Pulmonology Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients